B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Delanzomib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Delanzomib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

carfilzomib
6 shared targets
marizomib
3 shared targets
ixazomib
3 shared targets
epoxomycin
3 shared targets
mg
3 shared targets
oprozomib
2 shared targets
lactacystin
2 shared targets
boceprevir
2 shared targets
telaprevir
2 shared targets
Reserpine
6 shared targets · score 41.7
Loading evidence profile...

This evidence profile for Delanzomib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.